Few oligo-amenorrheic athletes have vasomotor symptoms

Maturitas

Volumn 34, Issue 3, 2000, Pages 219-225

  Hammar, Mats L ^a   Hammar Henriksson, Malin B ^a   Frisk, Jessica ^a   Rickenlund, Anette ^b   Wyon, Yvonne A M ^a  

^a Fac Hlth S   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Athletic amennorrhea; Exercise; Hot flushes; Postmenopausal women; Vasomotor symptoms

Indexed keywords

BETA ENDORPHIN;

ADULT; AMENORRHEA; ARTICLE; ATHLETE; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; OLIGOMENORRHEA; PREVALENCE; SWEDEN; THERMOREGULATION; VASOMOTOR REFLEX;

ADULT; AMENORRHEA; EXERCISE; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PREMENOPAUSE; PREVALENCE; QUESTIONNAIRES; SWEDEN;

EID: 0034737519     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00115-2     Document Type: Article

References (37)

1. McKinlay S.M., Brambilla D.J., Posner J.G. The normal menopause transition. Maturitas. 14:1992;103-115.
2. Berg G., Gottvall T., Hammar M., Lindgren R. Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986. Maturitas. 10:1988;193-199.
3. Rebar R., Spitzer L. The physiology and measurements of hot flushes. Am. J. Obstet. Gynecol. 156:1987;1284-1288.
4. Sturdee D.W., Brincat M. The hot flush. Studd J., Whitehead M. The Menopause. 1988;24-42 Blackwell Scientific, Oxford.
5. Meldrum D.R., Erlik Y., Lu J.K.H., Judd H.L. Objectively recorded hot flushes in patients with pituitary insufficiency. J. Clin. Endocrinol. Metab. 52:1981;684-687.
6. Grossman A. Opioid peptides and reproductive function. Speroff L., Lobo R. Role of Opioid Peptides in Reproductive Endocrinology. Seminars in Reproductive Endocrinology. 5, No 2:1987;115-124 Thieme Medical, New York.
7. Shoupe D., Lobo R. Endogenous opioids in the menopause. Speroff L., Lobo R. Role of Opioid Peptides in Reproductive Endocrinology. Seminars in Reproductive Endocrinology. 5, No. 2:1987;199-206 Thieme Medical, New York.
8. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1990. Peptides. 12:1991;1407-1432.
9. Handler C.M., Geller E.B., Adler M.W. Effect of mu-, kappa-, and delta-selective opioid agonists on thermoregulation in the rat. Pharmacol. Biochem. Behav. 43:1992;1209-1216.
10. Cagnacci A., Melis G.B., Soldani R., Paoletti A.M., Fioretti P. Effect of steroids on body temperature in postmenopausal women. Role of endogenous opioids. Life Sci. 50:1992;515-521.
11. Erdelyi G.I. Gynecologic survey of female athletes. J. Sports Med. Phys. Fitness. 2:1962;174-178.
12. Dale E., Gerlach D.H., Wilhite A.L. Menstrual dysfunction in distance runners. Obstet. Gynecol. 54:1979;47-53.
13. Highet R. Athletic amenorrhea. An update on aetilogy, complications and management. Sports Med. 7:1989;82-108.
14. Lindholm C., Lindén Hirschberg A., Carlström K., von Schoultz B. Hormone anabolic/catabolic balance in female endurance athletes. Gynecol. Obstet. Invest. 36:1993;176-180.
15. Drinkwater B., Bruemner B., Chesnut C. Menstrual history as determinant of current bone density in young athletes. J. Am. Med. Assoc. 263:1990;545-548.
16. Bergqvist A., Bergh T., Hogström L., Mattsson S., Nordenskjold F., Rasmussen C. Effects of triptorelin versus placebo on the symptoms of endometriosis. Fertil. Steril. 69:1998;702-708.
17. Holaday J.W., Loh H.H., Hao Li C. Unique behavioral effects of β-endorphin and their relationship to thermoregulation and hypothalamic function. Life Sci. 2:1978;1525-1536.
18. De Meirleir K., Arentz T., Hollmann W., Vanhaelst L. The role of endogenous opiates in thermal regulation of the body during exercise. Br. Med. J. 290:1985;739-740.
19. Wardlaw S.L., Wehrenberg W.B., Ferin M., Antunes J.L., Frantz A.G. Effect of steroids on β-endorphin in hypophyseal portal blood. J. Clin. Endocrinol. Metab. 55:1982;877-881.
20. Wehrenberg W.B., Wardlaw S.L., Frantz A.G., Ferin M. β-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle. Endocrinology. 111:1982;879-881.
21. Chowen JJ, Argente L, Vician et al. Proopiomelanocortin messenger mRNA in hypothalamic neurons is increased by testosterone through aromatization to estradiol, Neuroendocrinology 1990;52:581-588.
22. Nappi C., Petralgia F., Gambardella A. et al. Relationship between cerebrospinal fluid β-endorphin and plasma pituitary-gonadal hormone levels in women. J. Endocrinol. Invest. 13:1990;149-153.
23. Fraioli F., Cappa M., Fabbri A. et al. Lack of endogenous opioid inhibitory tone on LH secretion in early puberty. Clin. Endocrinol. (Oxf.). 20:1984;299-305.
24. Petralgia F., Porro C., Facchinetti F. et al. Opioid control of LH secretion in humans, menstrual cycles, menopause and aging reduce the effect of naloxone but not of morphine. Life Sci. 38:1986;2103-2110.
25. Petralgia F., Bernasconi S., Lughetti L. et al. Naloxone-induced luteinizing hormone secretion in normal, precosios and delayed puberty. J. Clin. Endocrinol. Metab. 63:1986;1112-1116.
26. Reid R.L., Quigley M.E., Yen S.S.C. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women. J. Clin. Endocrinol. Metab. 57:1983;1107-1110.
27. Hammar M., Berg G., Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet. Gynecol. Scand. 69:1990;409-412.
28. Wyon Y., Lindgren R., Lundeberg T., Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause. 2:1995;3-12.
29. Han J.S., Terenius L. Neurochemical basis of acupuncture analgesia. Ann. Rev. Pharmacol. Toxicol. 22:1982;193-220.
30. Hohtari H., Salminen-Lappalainen K., Laatikainen T. Response of plasma endorphins, corticotropin, cortisol, and luteinizing hormone in the corticotropin-releasing hormone stimulation test in eumenorrheic and amenorrheic athletes. Fertil. Steril. 55:1991;276-280.
31. Veldhuis J.D., Evans W.S., Demers L.M., Thorner M.O., Wakat D., Rogol A.D. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J. Clin. Endocrinol. Metab. 61:1985;557-563.
32. Cumming D.C., Vickovic M.M., Wall S.R., Fluker M.R. Defects in pulsatile release in normally emnstruating runners. J. Clin. Endocrinol. Metab. 60:1985;810-812.
33. Cumming D.C., Vickovic M.M., Wall S.R., Fluker M.R., Belcastro A. The effect of acute exercise on pulsatile release of luteinizing hormone in women runners. Am. J. Obstet. Gynecol. 153:1985;482-485.
34. Loucks A.B., Mortola J.F., Girton L., Yen S.S.C. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamus-pituitary-adrenal axes in athletic women. J. Clin. Endocrinol. Metab. 68:1989;402-411.
35. Barbarino A., de Marinis L., Tofani A. et al. Gonadotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J. Clin. Endocrinol. Metab. 68:1989;523-528.
36. 2-adrenergic agonist. J. Clin. Endocrinol. Metab. 64:1987;755-762.
37. Armeanu M.C., Lambalk C.B., Berkhout G.M.J., Schoemaker J. Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH. Gynecol. Endocrinol. 6:1992;3-12.